Multiple Fixed Drug erythema: Case report
Keywords:
fixed drug erythema, fixed pigmented erythema, drug reaction, drug dermatitis, dermatosisAbstract
Fixed drug erythema is a skin reaction to ingesting drugs. It is associated with the administration of antibiotics, non-steroidal anti-inflammatory drugs and psychotropic drugs. It is characterized by the presence of erythematous-violaceous spots or blisters; when the evolution is not satisfactory, it leaves hyperpigmented grayish-blue spots. This report is presented with the objective of identifying warning signs and symptoms from the presentation of the disease and avoiding subsequent complications. A 56-year-old black female patient with a history of type 2 diabetes mellitus presented with hyperpigmented macular lesions on the face and neck. She has applied some medication without being indicated by specialists. The diagnosis is established by interview and dermatological examination. Early diagnosis and monitoring of the disease avoid complications and thus achieves a minimum of recurrences, aspects that improve the quality of life of patients.
Downloads
References
Villanueva OA, Ramírez GKM. Eritema pigmentado fijo secundario a ingesta de alopurinol. Rev Cent Dermatol Pascua. 2021;30(1):20-23. https://dx.doi.org/10.35366/100587
Rojas-Caraballo N, Machado-Mora Y, Lagos-Ordoñez KJ, Bordelois-Abdo JA, Mozo-Bigñotte A. Reacciones cutáneas adversas medicamentosas en el Hospital General Docente “Dr. Agostinho Neto”, Guantánamo 2018-2019. Rev Inf Cient [Internet]. 2020 [citado 23 Ene 2023]; 99(2):134-141. Disponible en:
http://www.revinfcientifica.sld.cu/index.php/ric/article/view/2811
Orjuela-Rodríguez T, Rojas-Cortés R, Vergara V, Aldunate F, Jiménez G, Orta IA, et al. Reacciones adversas a medicamentos utilizados para la COVID-19 en cinco países de América Latina. Rev Panam Salud Publica. 2022;46:e178. https://doi.org/10.26633/RPSP.2022.178
Ministerio de Sanidad y Política Social de España. Estudio IBEAS: prevalencia de efectos adversos en hospitales de Latinoamérica; 2020. Disponible en: https://www.paho.org/hq/dmdocuments/2010/ INFORME%20GLOBAL%20IBEAS.pdf Acceso el 3 de septiembre de 2020.
Montané E, Santesmases J. Reacciones adversas a medicamentos. Med Clin (Barc) [Internet]. 2020 [citado 19 oct 2023];154(5):178–84. Disponible en: http://dx.doi.org/10.1016/j.medcli.2019.08.007
Lobera Labairu T. ¿Qué es la alergia a medicamentos? Cap. 28. p.301-8. Libro de las enfermedades alérgicas. 2da. ed. Bilbao, España: Fundación BBVA. [Internet] 2021 [citado 12 oct 2023]. Disponible en: http://www.fbbva.es/alergia
Fustá-Novell X, Bosch-Amate X, Morgado-Carrasco D. Eritema fijo medicamentoso. Atención Primaria Práctica [Internet].2019;1(3):55–6. Disponible en: http://dx.doi.org/10.1016/j.appr.2019.02.002
Vázquez-Osorio I, Gonzalvo-Rodríguez P, Mallo-García S, Rodríguez-Díaz E. Exantema fijo medicamentoso ampolloso generalizado por metamizol. Piel (Barc, Internet) [Internet]. 2019 [citado 19 Oct 2023];34(8):474–6. Disponible en: http://dx.doi.org/10.1016/j.piel.2018.08.004
García López BE, Mondragón García D, Velasco Medina AA, Velázquez Samano G. Eritema pigmentado fijo secundario a AINE: Reporte de caso. Rev Alerg Mex [Internet]. 2023; 70(3):203. Disponible en: http://dx.doi.org/10.29262/ram.v70i3.1268
Kidon M, Blanca-Lopez N, Gomes E, Terreehorst I, Tanno L, Ponvert C, et al. EAACI/ENDA Position Paper: Diagnosis and management of hypersensitivity reactions to non‐steroidal anti‐inflammatory drugs (AINEs) in children and adolescents. Pediatr Allergy Immunol [Internet]. 2018 [citado 19 Oct 2023];29(5):469–80. Disponible en: http://dx.doi.org/10.1111/pai.12915
Zambernardi A, Label M. Reacciones cutáneas adversas a medicamentos: cómo identificar el desencadenante. Actas Dermosifiliogr [Internet]. 2018 [citado 19 Oct 2023]; 109(8):699–707. Disponible en: http://dx.doi.org/10.1016/j.ad.2018.02.017
Begoña Cueva C, Carretero Ares JL, González Delgado P, Fernández Sánchez J. Reacciones alérgicas a fármacos. Abordaje en atención primaria y en el hospital. FMC [Internet]. 2017 Jun-Jul [citado 23 Ene 2023];24(6):303-11. Disponible en: https://www.fmc.es/es-reacciones-alergicas-farmacosabordaje-atencion-articulo-S1134207217300580
Published
How to Cite
Issue
Section
License
Medimay protects copyright from the very first moment the submission is made, but upon publication it assumes a Creative Commons 4.0 (cc-by-nc) license, which allows the use of the work to share (copy and redistribute the material in any medium or format) and adapt (remix, transform and build from the material) as long as exclusive mention is made of the publication in the journal as a primary source, prohibiting its commercialization. The author always retains his/her right.
This site is licensed under a